Anti-CD70 Antibody (Cusatuzumab)
Catalog No.
F2099
Anti-CD70 Antibody (Cusatuzumab)
Featured Products
Cusatuzumab is a human-derived monoclonal antibody, mainly composed of IgG1 subtype. Its mechanism is to inhibit the growth and survival of tumor cells by targeting the CD70 molecule and blocking its interaction with CD27. Cusatuzumab is mainly used to treat acute myeloid leukemia (AML) and other hematological malignancies.
Dry ice
1864871-20-4
-80°C
2 years
Liquid
1 mg/mL
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
ARGX-110,
100 mM Pro 20 mM Arg pH 5.0.
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD70
Please avoid freeze-thaw cycles.